These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 11326643
1. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies. Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N. Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643 [Abstract] [Full Text] [Related]
2. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer]. Matsuda M, Shimizu Y, Chikamatsu E, Takayanagi K, Ishigure H, Murakami S, Odani K. Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576 [Abstract] [Full Text] [Related]
4. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [Abstract] [Full Text] [Related]
5. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Ozkan H, Kaya M, Cengiz A. Hepatogastroenterology; 2003 Mar; 50(53):1669-74. PubMed ID: 14571813 [Abstract] [Full Text] [Related]
6. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Schneider J, Schulze G. Anticancer Res; 2003 Mar; 23(6D):5089-93. PubMed ID: 14981971 [Abstract] [Full Text] [Related]
7. [Tumor markers for pancreatic and biliary tract cancer]. Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M. Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574 [Abstract] [Full Text] [Related]
8. [Diagnostic usefulness of Ca 19-9 antigen in cancer of the pancreas and neoplasms of the pancreato-biliary intersection]. Robles-Diáz G, Aceves G, Galván E. Gac Med Mex; 1990 Sep; 126(2):78-82; discussion 82-3. PubMed ID: 2387490 [Abstract] [Full Text] [Related]
9. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I. Anticancer Res; 1993 Sep; 13(5C):1883-7. PubMed ID: 8267397 [Abstract] [Full Text] [Related]
10. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses. Mataki Y, Takao S, Maemura K, Mori S, Shinchi H, Natsugoe S, Aikou T. Clin Cancer Res; 2004 Jun 01; 10(11):3807-14. PubMed ID: 15173089 [Abstract] [Full Text] [Related]
11. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer]. Nakahara M, Fujisawa K. Gan To Kagaku Ryoho; 1987 Nov 01; 14(11):3010-9. PubMed ID: 2445292 [Abstract] [Full Text] [Related]
12. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas]. Yamaguchi K, Nagano M, Torada N, Hamasaki N, Kawakita M, Tanaka M. Rinsho Byori; 2004 Apr 01; 52(4):336-9. PubMed ID: 15164602 [Abstract] [Full Text] [Related]
13. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease? Akdoğan M, Parlak E, Kayhan B, Balk M, Saydam G, Sahin B. Turk J Gastroenterol; 2003 Sep 01; 14(3):181-4. PubMed ID: 14655062 [Abstract] [Full Text] [Related]
14. [Tumor markers in the diagnosis of tumors in the subhepatic area]. Dufek V, Petrtýl J, Klener P, Chmel J. Vnitr Lek; 1994 Jun 01; 40(6):350-3. PubMed ID: 8073643 [Abstract] [Full Text] [Related]
15. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. Jiang XT, Tao HQ, Zou SC. Hepatobiliary Pancreat Dis Int; 2004 Aug 01; 3(3):464-8. PubMed ID: 15313690 [Abstract] [Full Text] [Related]
16. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases]. Czakó L, Takács T, Babarczy E, Dux L, Lonovics J. Orv Hetil; 1997 Nov 23; 138(47):2981-5. PubMed ID: 9432648 [Abstract] [Full Text] [Related]
17. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. Ohshio G, Manabe T, Watanabe Y, Endo K, Kudo H, Suzuki T, Tobe T. Am J Gastroenterol; 1990 Oct 23; 85(10):1370-6. PubMed ID: 2220731 [Abstract] [Full Text] [Related]
18. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice]. Skvortsov SV, Lytsar' BN, Kalinin AV, Dolinskiĭ AG. Klin Med (Mosk); 1992 Oct 23; 70(5-6):21-3. PubMed ID: 1279265 [Abstract] [Full Text] [Related]
19. Improved sensitivity of fuzzy logic based tumor marker profiles for diagnosis of pancreatic carcinoma versus benign pancreatic disease. Halm U, Rohde N, Klapdor R, Reith HB, Thiede A, Etzrodt G, Mössner J, Keller T. Anticancer Res; 2000 Oct 23; 20(6D):4957-60. PubMed ID: 11326646 [Abstract] [Full Text] [Related]
20. [Tumor markers in the upper intestinal tract--stomach and pancreas]. Pointner R, Conrad F, Schwab G. Wien Klin Wochenschr; 1989 Jul 14; 101(14):482-4. PubMed ID: 2773485 [Abstract] [Full Text] [Related] Page: [Next] [New Search]